Effect of Yiqi Yangyin Jiedu Huayu prescription on intestinal metabolites in liver cirrhosis with minimal hepatic encephalopathy： A study based on metabolomics
Journal Title: Journal of Clinical Hepatology - Year 2025, Vol 41, Issue 3
Abstract
[Objective] To investigate the effect of Yiqi Yangyin Jiedu Huayu prescription on minimal hepatic encephalopathy in liver cirrhosis based on intestinal metabolomics. [Methods] A total of 11 patients with liver cirrhosis who were hospitalized in Beijing Ditan Hospital， Capital Medical University， from March to May 2024， and were diagnosed with MHE based on psychometric hepatic encephalopathy score were enrolled as subjects， and 11 healthy family members of the patients were enrolled as control group. Fecal samples were collected for metabolomics analysis from the control group and the patients with MHE before and after treatment with Yiqi Yangyin Jiedu Huayu prescription， and a population cohort study was conducted to investigate the effect of Yiqi Yangyin Jiedu Huayu prescription on intestinal metabolism of patients with MHE. The Fisher’s exact test was used for categorical data between two groups； the independent samples t-test was used for comparison of normally distributed continuous data between two groups， the paired t-test was used for comparision before and after treatment within the same group， and the Wilcoxon rank-sum test was used for comparison of non-normally distributed continuous data between two groups. [Results] A total of 29 differentially expressed metabolites were detected between the MHE group and the control group， mainly amino acids， organic acids， organic amines， carbohydrates， fatty acids， and vitamins， and there were 12 upregulated metabolites and 17 downregulated metabolites in the MHE group， which were mainly enriched in the metabolic pathways of ornithine， branched-chain amino acid， and aromatic amino acid. After the treatment with Yiqi Yangyin Jiedu Huayu prescription， 80 differentially expressed metabolites were detected in the patients with MHE， mainly carbohydrates， organic acids， and amino acids， and there were 56 upregulated metabolites and 24 downregulated metabolites， which were mainly enriched in the metabolic pathways of ornithine， branched-chain amino acid， and aromatic amino acid. [Conclusion] Yiqi Yangyin Jiedu Huayu prescription can exert a therapeutic effect on patients with MHE by regulating intestinal metabolism.
Authors and Affiliations
Tingting JIANG, Qun ZHANG, Xianbo WANG, Yuyong JIANG, Xiaoli LIU, Hao YU, Zhiyun YANG
Keywords
Related Articles
- EP ID EP768465
- DOI 10.12449/JCH250312
- Views 6
- Downloads 0
New insights and prospects of drug-induced liver injury in the context of chronic cholestatic liver diseases
Patients with chronic cholestatic liver diseases face numerous challenges in the detection， assessment， and management of suspected drug-induced liver injury （DILI）， and in particular， it is difficult to distinguis...
Mechanism of action of thymic stromal lymphopoietin in a mouse model of acetaminophen-induced acute liver injury
[Objective] To investigate the role and mechanism of thymic stromal lymphopoietin （TSLP） in a mouse model of acetaminophen （APAP）-induced acute liver injury. [Methods] A total of 16 wild-type （WT） male C57BL/6J mic...
Public health management strategies： A pathway to eliminating viral hepatitis threats
This article reviews the results of the 2020 national epidemiological survey of chronic viral hepatitis and its public health significance and discusses the differences in standard treatment and management rates and publ...
Mechanism of action of sex hormones in regulating T cell-mediated autoimmune hepatitis： A study based on the phenomenon of female bias
Autoimmune hepatitis （AIH） is an autoimmune disease characterized by liver parenchymal destruction and chronic fibrosis， and it is often mediated by T cells. The pathogenesis of AIH involves multiple factors， includi...
Immunomodulatory effect of short-chain fatty acids in hepatic encephalopathy and its potential diagnostic value
Hepatic encephalopathy （HE） is a common complication of severe liver disease in the end stage， and it is urgently needed to improve the rate of effective treatment and clarify the pathogenesis of HE. The liver is a cr...